These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 11979956)
1. [Drugs in development for the treatment of osteoporosis:Raloxifene]. Taga M Nihon Rinsho; 2002 Mar; 60 Suppl 3():572-80. PubMed ID: 11979956 [No Abstract] [Full Text] [Related]
4. Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. Riggs BL; Melton LJ J Bone Miner Res; 2002 Jan; 17(1):11-4. PubMed ID: 11771656 [No Abstract] [Full Text] [Related]
5. [Effects of raloxifene on bone loss and fracture risk in the menopausal woman]. Vignot E; Meunier PJ Contracept Fertil Sex; 1999 Dec; 27(12):858-60. PubMed ID: 10676043 [TBL] [Abstract][Full Text] [Related]
6. [Evidence of raloxifene on postmenopausal osteoporosis]. Okano H Nihon Rinsho; 2007 Nov; 65 Suppl 9():374-80. PubMed ID: 18161135 [No Abstract] [Full Text] [Related]
7. Latest innovation in the treatment of osteoporosis: SERMs and the role of parathyroid hormone. Thiebaud D J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S124-5. PubMed ID: 21213508 [No Abstract] [Full Text] [Related]
8. Another selective estrogen-receptor modulator for osteoporosis. Becker C N Engl J Med; 2010 Feb; 362(8):752-4. PubMed ID: 20181977 [No Abstract] [Full Text] [Related]
9. [Which is the better choice, estrogen or SERMs in postmenopausal women?]. Shintani M Clin Calcium; 2004 Oct; 14(10):105-10. PubMed ID: 15577140 [TBL] [Abstract][Full Text] [Related]
10. Does raloxifene reduce risk of vertebral fractures? Is this another, brighter way to treat osteoporosis? Hathirat S; Evans MF Can Fam Physician; 2001 Oct; 47():1982-4. PubMed ID: 11723592 [No Abstract] [Full Text] [Related]
12. [SERM for early osteoporosis therapy. Risk for first spinal fracture reduced to half]. MMW Fortschr Med; 2003 May; 145(22):57. PubMed ID: 12866287 [No Abstract] [Full Text] [Related]
13. Who will benefit from treatment with selective estrogen receptor modulators (SERMs)? Sambrook P Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):975-81. PubMed ID: 16301191 [TBL] [Abstract][Full Text] [Related]
15. [Effects of SERMs on bone health. Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis]. Ohta H Clin Calcium; 2010 Mar; 20(3):315-21. PubMed ID: 20190360 [TBL] [Abstract][Full Text] [Related]
16. [Defining the role of raloxifene as a therapeutic agent for postmenopausal osteoporosis: focus on its pharmacological properties]. Ohta H Clin Calcium; 2004 Oct; 14(10):73-80. PubMed ID: 15577135 [TBL] [Abstract][Full Text] [Related]
17. Reduction of vertebral fracture risk with raloxifene. Bashore R J Fam Pract; 1999 Nov; 48(11):911-2. PubMed ID: 10907630 [No Abstract] [Full Text] [Related]